BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19407999)

  • 1. Unexpected foci of 18F-FDG uptake in the breast detected by PET/CT: incidence and clinical significance.
    Litmanovich D; Gourevich K; Israel O; Gallimidi Z
    Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1558-64. PubMed ID: 19407999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
    Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
    Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D
    J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of incidental finding of focal activity in the breast at 18F-FDG PET/CT.
    Kang BJ; Lee JH; Yoo IeR; Kim SH; Choi JJ; Jeong SH; Yim HW
    AJR Am J Roentgenol; 2011 Aug; 197(2):341-7. PubMed ID: 21785079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
    Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH
    Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT.
    Dunne RM; O'Mahony D; Wilson G; McDermott R; O'Keeffe SA
    Br J Radiol; 2013 Jun; 86(1026):20130034. PubMed ID: 23568361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
    Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
    Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric study on ¹⁸F-FDG-PET/CT breast incidental uptake in patients studied for non-breast malignant purposes.
    Bertagna F; Evangelista L; Piccardo A; Bertoli M; Bosio G; Giubbini R; Orlando E; Treglia G
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):24-9. PubMed ID: 25312053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does focal incidental 18F-FDG PET/CT uptake in the prostate have significance?
    Brown AM; Lindenberg ML; Sankineni S; Shih JH; Johnson LM; Pruthy S; Kurdziel KA; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Abdom Imaging; 2015 Oct; 40(8):3222-9. PubMed ID: 26239399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography and ultrasonography evaluation of unexpected focal 18F-FDG uptakes in breast on PET/CT.
    Kim MY; Cho N; Chang JM; Yun BL; Bae MS; Kang KW; Moon WK
    Acta Radiol; 2012 Apr; 53(3):249-54. PubMed ID: 22262866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
    Caprio MG; Cangiano A; Imbriaco M; Soscia F; Di Martino G; Farina A; Avitabile G; Pace L; Forestieri P; Salvatore M
    Radiol Med; 2010 Mar; 115(2):215-24. PubMed ID: 20017002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast incidentalomas on 18-Fluorodeoxyglucose positron emission tomography-computed tomography performed for a non-mammary cause: Significance and outcomes.
    Menon P; Bourke A
    J Med Imaging Radiat Oncol; 2023 Jun; 67(4):357-364. PubMed ID: 36468633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology.
    Karam M; Roberts-Klein S; Shet N; Chang J; Feustel P
    J Nucl Med; 2008 Sep; 49(9):1429-36. PubMed ID: 18765585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?
    van Hoeij FB; Keijsers RG; Loffeld BC; Dun G; Stadhouders PH; Weusten BL
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):66-71. PubMed ID: 25139518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental colonic focal lesions detected by FDG PET/CT.
    Gutman F; Alberini JL; Wartski M; Vilain D; Le Stanc E; Sarandi F; Corone C; Tainturier C; Pecking AP
    AJR Am J Roentgenol; 2005 Aug; 185(2):495-500. PubMed ID: 16037527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
    Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images.
    Han EJ; H O J; Choi WH; Yoo IR; Chung SK
    Br J Radiol; 2010 Nov; 83(995):915-20. PubMed ID: 20965901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.